Dyne Therapeutics CEO Joshua Brumm's 2020 pay jumps 981% to $12M
Dyne Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 14, 2021
Dyne Therapeutics reported fiscal year 2020 executive compensation information on April 14, 2021.
In 2020, three executives at Dyne Therapeutics received on average a compensation package of $6.7M, a 1,834% increase compared to previous year.
Average pay of disclosed executives at Dyne Therapeutics
Joshua Brumm, Chief Executive Officer, received $12M in total, which increased by 4,180% compared to 2019. 67% of Brumm's compensation, or $7.9M, was in option awards. Brumm also received $300K in non-equity incentive plan, $483K in salary, $3.1M in stock awards, as well as $6.9K in other compensation.
Romesh Subramanian, Chief Scientific Officer, received a compensation package of $4.4M, which increased by 962% compared to previous year. 64% of the compensation package, or $2.8M, was in option awards.
Susanna High, Chief Operating Officer, earned $3.7M in 2020.
Related executives
You may also like
Source: SEC filing on April 14, 2021.